Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 39

Daily Deal Round Up: September 24, 2021

Sleep apnoea treatment developer Cryosa raised $21m in a Hoya-backed series B round while CommerzVentures led a $17m round for financial tool developer Doconomy .

Sep 24, 2021

Garuda gets underway with $72m

Co-founded by Harvard faculty, Garuda has launched with $72m in series A financing to advance blood stem cell therapies.

Sep 24, 2021

Garuda gets underway with $72m

Mass General Brigham Ventures was among the participants in a series A round announced at the launch of the blood stem cell-focused startup.

Sep 24, 2021

Daily Deal Round Up: September 23, 2021

Oxygen therapy developer Aviv Scientific completed a $40m series B round led by Danel while drug delivery system developer Credence raised almost as much.

Sep 23, 2021

Daily deal net: September 23, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 23, 2021

Daily Deal Round Up: September 21, 2021

Daiichi Life helped sales technology provider BellFace take its total funding above $80m while ZKTube Labs and Boom Entertainment each raised $15m.

Sep 21, 2021

Daily deal net: September 21, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 21, 2021

Altana gets $15m funding allocation

The supply data software developer pulled in $15m through a GV-led round that included Floating Point, Ridgeline Partners, Amadeus Capital Partners and Schematic Ventures.

Sep 21, 2021

Daily deal net: September 20, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 20, 2021

Anjarium apprehends $60m in series A funding

Pfizer Ventures participated in a series A round for genetic therapeutics developer Anjarium Biosciences that was co-led by Abingworth and Gimv.

Sep 20, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here